Direct access to genetic services was reported in 48 programs (Table 3), predominantly for BRCA1/2, Lynch syndrome (Pichert and Stahel, 2000; Hopwood et al., 2003; Henriksson et al., 2004; Epplein et al., 2005; Pujol et al., 2013), and newborn screening (Byck et al., 2006; Puryear et al., 2006; Little et al., 2009; Metcalfe et al., 2009). This evidence concerns the gene BRCA1 and Lynch syndrome.